Daisuke Hashimoto, Sohei Satoi, Tsutomu Fujii, Masayuki Sho, Jin He, Thilo Hackert, Marco Del Chiaro, Jin-Young Jang, Aiste Gulla, Yoo-Seok Yoon, Yan-Shen Shan, Wenhui Lou, Roberto Valente, Junji Furuse, Atsushi Oba, Minako Nagai, Taichi Terai, Haruyoshi Tanaka, Ayano Sakai, Tomohisa Yamamoto, So Yamaki, Ippei Matsumoto, Yoshiaki Murakami, Kyoichi Takaori, Yoshifumi Takeyama
Pancreatic ductal adenocarcinoma (PDAC) is a typical refractory malignancy, and many patients have distant organ metastases at diagnosis, such as liver metastasis and peritoneal dissemination. The standard treatment for unresectable PDAC with distant organ metastasis (UR-M) is chemotherapy, but the prognosis remained poor. However, with recent dramatic developments in chemotherapy, the prognosis has gradually improved, and some patients have experienced marked shrinkage or disappearance of their metastatic lesions...
July 20, 2023: Pancreatology: Official Journal of the International Association of Pancreatology (IAP) ... [et Al.]